Cinctive Capital Management LP Sage Therapeutics, Inc. Transaction History

Cinctive Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $1.1 Million - $1.52 Million	-39,979 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $528,212 - $786,212	-17,200 Reduced 30.08%	39,979 $1.32 Million
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $658,889 - $837,568	17,779 Added 45.12%	57,179 $2.43 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $1.59 Million - $2.26 Million	39,400 New	39,400 $1.75 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.